Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Groupe Oncologie Radiotherapie Tete et Cou

10 clinical trials

Clinical trial
A Phase III Randomized Study of Chemo-radiotherapy Versus Radiotherapy Alone in the Adjuvant Treatment of Salivary Glands and Nasal Tumors (IMRT or Protontherapy)
Status: Recruiting, Estimated PCD: 2030-02-01
Clinical trial
A Double-blind, Randomized, Phase III Study of Radiotherapy Combined With cetuXimab + Xevinapant Compared to Radiotherapy Combined With Cetuximab (Standard of Care) + Placebo in Patients With LA SCCHN, Unfit for High-dose Cisplatin
Status: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
A Phase II Trial of Radiotherapy (RT)-Durvalumab Without Prophylactic Neck Irradiation in Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Status: Active (not recruiting), Estimated PCD: 2026-07-01
Clinical trial
Randomized Phase II Trial Comparing Chemotherapy Combined With Stereotactic Radiotherapy and Stereotactic Radiotherapy Alone, for Treatment of Oligometastases in Squamous Cell Cancers of the Upper Aerodigestive Tract
Status: Active (not recruiting), Estimated PCD: 2026-07-01
Clinical trial
A Phase III Randomized Trial of Avelumab-cetuximab-Radiotherapy Versus Standards of Care in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status: Active (not recruiting), Estimated PCD: 2027-12-01
Clinical trial
Phase III Trial of Laryngeal Preservation Comparing Induction Chemotherapy With Cisplatin, 5-fluorouracil and Docetaxel (TPF) Followed by Radiotherapy and Concomitant Administration of Radiotherapy With Cisplatin
Status: Active (not recruiting), Estimated PCD: 2028-10-01
Clinical trial
A Phase III Randomized Trial of Post-operative Adjuvant Nivolumab and Concomitant Chemo-radiotherapy in High-risk Patients With Resected Squamous Cell Carcinoma of Head and Neck
Status: Recruiting, Estimated PCD: 2027-08-01
Clinical trial
A Phase II Randomized Study to Determine the Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With Radiation Therapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status: Completed, Estimated PCD: 2022-10-01
Clinical trial
A Phase Ib Study of OBT076 or OBT076 Followed by Balstilimab in Patients With Recurrent or Metastatic (R/M) Adenoid Cystic Carcinoma (AdCC) of the Head and Neck (H&N)
Status: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
A Phase II Randomized Trial, Non Comparative, Evaluating Chemotherapy Associated Cisplatin, 5-fluorouracil and Docetaxel at Adapted Doses in Patients With Locally Advanced Squamous Cell Carcinoma
Status: Active (not recruiting), Estimated PCD: 2025-06-01